Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:931-936

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.

(Hypertension. 1999;34:931-936.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Gender Differences in Ca2+ Entry Mechanisms of Vasoconstriction in Wistar-Kyoto and Spontaneously Hypertensive Rats

Janice K. Crews; Jason G. Murphy; Raouf A. Khalil

From the Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—We investigated whether putative vascular protection against hypertension in females reflects differences in the Ca2+ mobilization mechanisms of vasoconstriction depending on the gender and the status of the gonads. Active stress and 45Ca2+ influx were measured in aortic strips isolated from intact and gonadectomized male and female Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). In aortic strips of intact male WKY incubated in normal Krebs' solution (2.5 mmol/L Ca2+), both phenylephrine (10-5 mol/L) and membrane depolarization by 96 mmol/L KCl caused significant increases in active stress and 45Ca2+ influx. In intact female WKY, the phenylephrine- and KCl-induced stress and 45Ca2+ influx were significantly reduced. In Ca2+-free (2 mmol/L EGTA) Krebs' solution, stimulation of aortic strips with phenylephrine or caffeine (25 mmol/L) to induce Ca2+ release from intracellular stores caused a transient increase in stress that was not significantly different between males and females. In SHR, the phenylephrine- and KCl-induced stress and 45Ca2+ influx were significantly greater than those in WKY in all groups of rats. The reduction in stress and Ca2+ entry in intact females compared with intact males was greater in SHR than in WKY. The contractile responses and Ca2+ entry in castrated male and ovariectomized female WKY or SHR were not significantly different from the respective responses in intact males. The contractile responses and Ca2+ entry in ovariectomized female WKY or SHR with 17ß-estradiol implant were not significantly different from the respective responses in intact females. Thus, the phenylephrine- and depolarization-induced vascular reactivity and Ca2+ entry in vascular smooth muscle are dependent on gender and on the presence or absence of functional female gonads. Ca2+ release from intracellular stores is not affected by gender or gonadectomy. The gender-specific changes in vascular reactivity and Ca2+ entry are augmented in hypertension.


Key Words: hormones • muscle, smooth, vascular • constriction • gender • calcium


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Hypertension is a major cardiovascular disease in the industrialized world. The greater incidence of hypertension in men and postmenopausal women than in premenopausal women1 2 has suggested vascular protective effects of female sex hormones in premenopausal women.3 The beneficial effects of estrogen replacement therapy in postmenopausal women4 have further supported a protective role for estrogen against hypertension.

The beneficial vascular effects of estrogen have been ascribed to a variety of factors, including endothelium-dependent vascular relaxation5 6 and endothelium-independent vascular relaxation, that involve direct action on vascular smooth muscle.2 3 7 8 Vascular smooth muscle contraction is triggered by increases in intracellular [Ca2+] due to Ca2+ release from the intracellular stores and Ca2+ entry from the extracellular space.9 We and others have reported that estrogen causes rapid relaxation of isolated segments of vascular smooth muscle7 8 10 and have suggested additional mechanisms independent of the classic genomic pathway of steroid action11 possibly mediated by an effect on Ca2+ mobilization and/or fluxes.

The suggested vascular protective effects of estrogen in females1 2 as opposed to their proposed absence in males12 imply gender-specific differences in vascular smooth muscle contractility. Additionally, the suggested vascular protective effects of estrogen in females with intact gonads as opposed to their proposed absence in females with reduced gonadal functions1 2 3 4 imply that vascular smooth muscle contractility may be modified by the presence or absence of functional female gonads. However, little is known about the effect of gender and the status of the gonads on the Ca2+ mobilization mechanisms of vascular smooth muscle contraction. In addition, since hypertension is often associated with changes in vascular reactivity,13 14 15 16 it is predicted that the gender-dependent changes in vascular reactivity may be altered in cases of hypertension. However, whether the effects of gender and the status of the gonads on vascular reactivity and the Ca2+ mobilization mechanisms of vasoconstriction are modified in hypertension is unclear.

The purpose of this study was as follows: (1) to determine whether vascular smooth muscle contractility is modified by gender and by the presence or absence of gender-specific gonads; (2) to determine whether the gender-specific changes in vascular reactivity reflect changes in the Ca2+ mobilization mechanisms of vascular smooth muscle contraction, ie, Ca2+ release from the intracellular stores and Ca2+ entry from the extracellular space; and (3) to determine whether the gender-specific changes in vascular contractility and Ca2+ mobilization mechanisms are modified in animal models of hypertension.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) (aged 12 weeks, Harlan) were housed in the animal facility and maintained on ad libitum standard rat chow and tap water in a 12-hour light/12-hour dark cycle. Both WKY and SHR were divided into 4 groups: intact males (n=12), intact females (n=12), castrated males (n=12), and ovariectomized (OVX) females (n=12). Gonadectomy was performed and verified by the vendor at 8 weeks of age. Some OVX female WKY (n=8) and SHR (n=8) were given subcutaneous timed-release 17ß-estradiol implants (30-day release, 0.125 mg per pellet, Innovative Research of America) 3 days after ovariectomy and were studied 4 weeks later. All procedures were performed in accordance with the guidelines of the Animal Care and Use Committee at the University of Mississippi Medical Center and the American Physiological Society.

Blood Samples
On the day of the experiment, the rats were anesthetized by inhalation of isoflurane. Blood was collected for measurement of plasma 17ß-estradiol by radioimmunoassay with the use of a 17ß-estradiol kit (ICN Biomedicals). In WKY, plasma 17ß-estradiol was 16±2 pmol/L (n=12) in intact males, 77±8 pmol/L (n=12) in intact females, 18±3 pmol/L (n=12) in castrated males, 17±2 pmol/L (n=12) in OVX females, and 83±9 pmol/L (n=8) in OVX females with 17ß-estradiol implants. The plasma 17ß-estradiol in SHR was not significantly different from that in WKY in each group of rats.

Isometric Tension
The thoracic aorta was excised, placed in oxygenated Krebs' solution, and cleaned of connective tissue. The aorta was cut transversely into 3-mm-wide rings. The endothelium was removed by rubbing the vessel interior with forceps. Aortic rings were cut open into strips. One end of the strip was attached to a glass hook with a thread loop, and the other end was connected to a Grass force transducer (FT03, Astro-Med). Aortic strips were stretched to maximum length (1.5 initial unloaded length) and allowed to equilibrate for 1 hour in a water-jacketed, temperature-controlled tissue bath filled with 50 mL Krebs' solution continuously bubbled with 95% O2/5% CO2 at 37°C. The changes in isometric tension were recorded on a Grass polygraph (model 7D, Astro-Med). Removal of the endothelium was routinely verified by the absence of acetylcholine (10-6 mol/L)–induced vasorelaxation in aortic strips precontracted with phenylephrine (3x10-7 mol/L).

Three different agonists were used. The {alpha}-adrenergic agonist phenylephrine was used to stimulate both Ca2+ release from the intracellular Ca2+ stores and Ca2+ entry from the extracellular space.17 Caffeine was used to activate Ca2+-induced Ca2+ release in Ca2+-free solution.18 Membrane depolarization by high KCl solution was used to activate Ca2+ entry from the extracellular space.9 17

Three protocols were followed in the present study. In the first protocol, the tissues were incubated in normal Krebs' solution (2.5 mmol/L Ca2+), and a maximal control contraction to phenylephrine (10-5 mol/L) was elicited. In some strips, when maximal phenylephrine contraction or contraction to the ED50 of phenylephrine (3x10-7 mol/L) reached a plateau, 17ß-estradiol was added at increasing concentrations, and the changes in tension were observed. In the second protocol, the bathing solution was changed to 96 mmol/L KCl solution to elicit a maximal contraction. In the third protocol, the tissues were incubated in normal Krebs' solution (2.5 mmol/L Ca2+) for 1 hour, transferred to Ca2+-free (2 mmol/L EGTA) Krebs' solution for 10 minutes, then stimulated with phenylephrine (10-5 mol/L) or caffeine (25 mmol/L) for 2 minutes or until the transient contraction returned to baseline.

45Ca2+ Influx
Aortic strips were incubated in normal Krebs' solution for 1 hour, then stimulated with phenylephrine (10-5 mol/L) or 96 mmol/L KCl for 15 minutes. In some experiments, the tissues were pretreated with 17ß-estradiol (10-6 mol/L) for 30 minutes before stimulation with phenylephrine. The tissues were transferred to the respective radioactive 45Ca2+-labeled (ICN Radiochemical) solution (specific activity, 2 µCi/mL) for 90 seconds, then transferred to ice-cold Ca2+-free (2 mmol/L EGTA) Krebs' solution for 45 minutes to quench extracellular 45Ca2+ label.17 The tissue samples were weighed and placed in 2 mL hypotonic (5 mmol/L) EDTA for 24 hours at 4°C to disrupt the cell membranes and release the intracellular content of 45Ca2+. The next day, 4 mL of Ecolite scintillation cocktail was added, and the samples were counted in a scintillation counter (Beckman LS 6500).

Solutions, Drugs, and Chemicals
Normal Krebs' solution contained the following (in mmol/L): NaCl 120, KCl 5.9, NaHCO3 25, NaH2PO4 1.2, dextrose 11.5, MgCl2 1.2, CaCl2 2.5, at pH 7.4. For Ca2+-free Krebs' solution, CaCl2 was omitted and replaced with 2 mmol/L EGTA. The high-KCl depolarizing solution was prepared as Krebs' but with equimolar substitution of NaCl with KCl. Stock solution of phenylephrine (L-phenylephrine HCl; Sigma) was prepared as 10-1 mol/L in distilled water. Caffeine (Sigma) was prepared as 25 mmol/L in Ca2+-free Krebs'. All other chemicals were of reagent grade or better.

Statistical Analysis
The developed force was normalized for the cross-sectional area of each individual strip and expressed as active stress (N/m2) according to the equation Stress=Force/Cross-Sectional Area, where cross-sectional area=wet weight/(tissue densityxlength of the strip) and tissue density=1.055 g/cm3. Data were analyzed and expressed as mean±SEM. Data were compared by ANOVA with 3 classification criteria (strain, gender, and treatment [gonadectomized versus intact]). Scheffé's F test was used for comparison of multiple means. Student's t test for unpaired data was used for comparison of 2 means. Differences were considered statistically significant at P<0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
In normal Krebs' solution (2.5 mmol/L Ca2+), phenylephrine (10-5 mol/L) caused contraction of aortic strips that reached a plateau at {approx}15 minutes, and therefore the phenylephrine response was compared at this time in all groups of rats. Phenylephrine increased active stress to 15.92±0.65x103 N/m2 (n=8) in intact male WKY (Figure 1A). The phenylephrine-induced stress was significantly reduced by 20% in intact female WKY. The phenylephrine-induced stress was not significantly different between intact and castrated males but was significantly greater in OVX females than in intact females. There was no significant difference in the phenylephrine-induced stress between OVX females and castrated males. In OVX female WKY with 17ß-estradiol implants, the phenylephrine-induced stress was not significantly different from that in intact female WKY. In SHR, the phenylephrine-induced active stress was significantly greater than that of WKY in all groups of rats. The phenylephrine-induced stress in intact females SHR was reduced by 30% compared with that in intact male SHR.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Active stress (A) and 45Ca2+ influx (B) in response to phenylephrine (Phe) (10-5 mol/L) in aortic strips from WKY and SHR intact male, intact female, castrated male, OVX female, and OVX female rats with 17ß-estradiol implants. Data bars represent the mean±SEM of measurements in 10 to 20 individual aortic strips from 5 to 6 rats of each group. *SHR are significantly different (P<0.05) from WKY. #Intact female WKY and OVX female WKY with 17ß-estradiol implants are significantly different from other groups of WKY. {dagger}Intact female SHR and OVX female SHR with 17ß-estradiol implants are significantly different from other groups of SHR.

We investigated whether the observed gender differences in active stress reflect changes in Ca2+ release from the intracellular stores. In Ca2+-free (2 mmol/L EGTA) Krebs' solution, phenylephrine (10-5 mol/L) and caffeine (25 mmol/L) caused a transient increase in active stress in the aorta of intact male WKY, which was not significantly different from that in WKY or SHR intact female, castrated male, OVX female, or OVX female rats with 17ß-estradiol implants (Table).


View this table:
[in this window]
[in a new window]
 
Table 1. Active Stress (x103 N/m2) Induced by Phenylephrine (10-5 mol/L) and Caffeine (25 mmol/L) in Rat Aortic Strips Incubated in Ca2+-Free (2 mmol/L EGTA) Krebs' Solution

We tested whether the observed gender differences in active stress reflect changes in Ca2+ entry from the extracellular space. In unstimulated tissues, the basal Ca2+ influx was 13.1±1.2 µmol/kg per minute (n=20) in the aorta of intact male WKY, which was slightly but not significantly greater than or lower than that in intact female, castrated male, or OVX female WKY. Phenylephrine increased Ca2+ influx to 24.2±1.2 µmol/kg per minute (n=20) in intact male WKY (Figure 1B). The phenylephrine-induced increases in Ca2+ influx were significantly reduced by 20% in intact female WKY. The phenylephrine-induced Ca2+ influx was not significantly different between intact males and castrated males but was significantly greater in OVX females than in intact females. There was no significant difference in the phenylephrine-stimulated Ca2+ influx between OVX female and castrated male WKY. In OVX female WKY with 17ß-estradiol implants, the phenylephrine-induced Ca2+ influx was not significantly different from that in intact female WKY (Figure 1B). In SHR, the phenylephrine-induced Ca2+ influx was significantly greater than that of WKY in all groups of rats. The phenylephrine-induced Ca2+ influx in intact female SHR was reduced by 28% compared with that in intact male SHR.

To investigate the possible Ca2+ entry pathway involved, we measured active stress and Ca2+ influx in the presence of 96 mmol/L KCl. Membrane depolarization by 96 mmol/L KCl is known to stimulate Ca2+ entry through voltage-gated Ca2+ channels.9 17 KCl caused a contraction that reached a plateau at {approx}15 minutes, and therefore the KCl response was compared at this time in all groups of rats. KCl increased active stress to 13.91±0.62x103 N/m2 (n=12) (Figure 2A) and Ca2+ influx to 28.2±1.5 µmol/kg per minute (n=20) (Figure 2B) in the aorta of intact male WKY. The KCl-induced stress and Ca2+ influx were significantly reduced by 19% and 21%, respectively, in intact female WKY. The KCl-induced responses were not significantly different between intact and castrated males but were significantly greater in OVX females than in intact females. There was no significant difference in KCl-induced stress or Ca2+ influx between OVX female and castrated male WKY. In OVX female WKY with 17ß-estradiol implants, the KCl-induced stress and Ca2+ influx were not significantly different from those in intact female WKY (Figure 2). In SHR, the KCl-induced active stress and Ca2+ influx were significantly greater than those of WKY in all groups of rats. The KCl-induced active stress and Ca2+ influx in intact female SHR were reduced by 28% and 27%, respectively, compared with those in intact male SHR.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Active stress (A) and 45Ca2+ influx (B) in response to 96 mmol/L KCl in aortic strips from WKY and SHR intact male, intact female, castrated male, OVX female, and OVX female rats with 17ß-estradiol implants. Data bars represent the mean±SEM of measurements in 10 to 20 individual aortic strips from 5 to 6 rats of each group. *SHR are significantly different (P<0.05) from WKY. #Intact female WKY and OVX female WKY with 17ß-estradiol implants are significantly different from other groups of WKY. {dagger}Intact female SHR and OVX female SHR with 17ß-estradiol implants are significantly different from other groups of SHR.

Since the gender difference could involve a multitude of factors in vivo, we tested the direct effect of exogenous application of 17ß-estradiol on maximal phenylephrine- and KCl-induced contraction and Ca2+ influx. 17ß-Estradiol caused concentration-dependent relaxation of phenylephrine-induced contraction. As shown in Figure 3A, 17ß-estradiol was more potent in inhibiting the phenylephrine-induced stress in OVX female SHR (IC50=4.0±0.2x10-7 mol/L; n=12) than OVX female WKY (IC50=1.2±0.2x10-6 mol/L; n=12). In OVX female WKY, when contraction to EC50 of phenylephrine (3x10-7 mol/L) was elicited and then 17ß-estradiol was added, the IC50 for 17ß-estradiol was 1.1±0.2x10-6 mol/L; n=8), which was not significantly different from that when maximal contractions to phenylephrine (10-5 mol/L) were generated, and 17ß-estradiol was then added (IC50=1.2±0.2x10-6 mol/L; n=12). In addition, 17ß-estradiol (10-6 mol/L) caused greater inhibition of phenylephrine-induced Ca2+ entry in OVX female SHR (30%) than OVX female WKY (23%) (Figure 3C). Similarly, 17ß-estradiol was more potent in inhibiting the KCl-induced stress in OVX female SHR (IC50=3.8±0.3x10-7 mol/L; n=12) than OVX female WKY (IC50=1.0±0.1x10-6 mol/L; n=12) (Figure 3B). 17ß-Estradiol (10-6 mol/L) also caused greater inhibition of KCl-induced Ca2+ entry in OVX female SHR (34%) than in OVX female WKY (19%) (Figure 3D).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. Effect of 17ß-estradiol on maximal 10-5 mol/L phenylephrine- and 96 mmol/L KCl-induced contraction (A and B) and 45Ca2+ influx (C and D) in aortic strips from OVX female WKY and SHR. Data points represent the mean±SEM of measurements in 12 to 20 aortic strips from 5 to 6 rats of each group. *SHR is significantly different (P<0.05) from WKY. #17ß-Estradiol (10-6 mol/L)–induced decrease in Ca2+ influx in aortic strips of OVX female WKY is significantly different from control OVX WKY. {dagger}17ß-Estradiol (10-6 mol/L)– induced decrease in Ca2+ influx in aortic strips of OVX female SHR is significantly different from control OVX SHR.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The main findings of the present study are as follows: (1) Vascular reactivity due to Ca2+ entry into vascular smooth muscle, but not Ca2+ release from intracellular stores, is reduced in the presence and enhanced in the absence of female gonads. (2) Estrogen replacement in OVX female WKY reduces vascular reactivity and Ca2+ entry to levels similar to those in intact female WKY. (3) Exogenous application of estrogen to vascular strips reduces vascular reactivity and Ca2+ entry in OVX female WKY. (4) The reduction in vascular reactivity and Ca2+ entry in intact females, in OVX females with estrogen implants, or in response to exogenous application of estrogen on isolated vascular strips of OVX females is greater in SHR than in WKY.

The present study showed that the maximum aortic contraction to the {alpha}-adrenergic agonist phenylephrine was greater in intact male than in intact female WKY. These results are consistent with other studies that have shown a greater contraction to vasopressin in the aorta of intact male than intact female rats.19 The observation that the vascular contractility was not significantly different in castrated males compared with intact males but was significantly enhanced in OVX females compared with intact females suggests that the gender differences are less likely related to androgens and more likely related to estrogens. Since the expression of sex hormone receptors in arterial smooth muscle may vary depending on the gender and the status of the gonads,20 the observed gender differences in the vascular reactivity to estrogen may well be related to the relative abundance of estrogen receptors. This is supported by reports that estrogen receptors have been identified in the rat aorta21 22 23 and that females have higher levels of estrogen receptors in their arteries than males.24 However, the gender differences may also be related to differences in the signaling mechanisms downstream from receptor activation. We investigated whether the gender differences in vascular reactivity reflect differences in the mechanisms of Ca2+ mobilization in smooth muscle. Phenylephrine-induced contraction is triggered by an initial inositol 1,4,5-trisphosphate (IP3)–induced Ca2+ release from intracellular stores and maintained Ca2+ entry from the extracellular space.9 17 We found that the transient phenylephrine contraction in Ca2+-free medium was not significantly different among the different groups of rats, suggesting that the IP3-induced Ca2+ release mechanism is not affected by gender. Furthermore, caffeine, which stimulates the Ca2+-induced Ca2+ release mechanism,9 18 caused a transient contraction that was similar in magnitude in the different groups of rats, suggesting that the observed gender differences in vascular reactivity are not related to the Ca2+-induced Ca2+ release mechanism.

Membrane depolarization by high KCl is known to mainly stimulate Ca2+ entry from the extracellular space.9 17 The observation that the KCl-induced contraction was greater in intact males than in intact females suggested gender differences in Ca2+ entry mechanisms. In addition, the enhanced KCl-induced contraction in OVX females compared with that in intact females lends support to the contention that the gender differences are more likely related to endogenous estrogens. This is also supported by the observations that the phenylephrine- and KCl-induced increases in aortic Ca2+ entry were reduced in the presence and enhanced in the absence of female gonads. The causes of the gender differences in Ca2+ entry are not clear but may be related to the plasmalemmal density and/or the permeability of the Ca2+ entry pathways, among other factors. This is supported by reports that the expression of the L-type Ca2+ channels in cardiac muscle is substantially increased in estrogen receptor–deficient mice.25

We found that the vascular reactivity and Ca2+ entry in OVX female WKY with estrogen implant were not significantly different from those in intact female WKY, providing further evidence that endogenous estrogens may be involved in the observed gender differences. However, the observed gender differences in the mechanisms of Ca2+ mobilization in vascular smooth muscle could be due to a multitude of effects of sex hormones in vivo. On the other hand, we found that exogenous application of estrogen to vascular strips of OVX females caused significant inhibition of vascular reactivity and Ca2+ entry. These results are consistent with the reduced vascular reactivity observed in aortic strips of intact female rats and are in agreement with reports that estrogen causes vascular relaxation in preconstricted rabbit and porcine coronary artery.7 8 10 However, on the basis of these results we do not wish to draw conclusions on whether estrogen inhibits Ca2+ entry by direct or indirect action on plasmalemmal Ca2+ channels. Other studies have shown that estrogen blocks Ca2+ channels in cultured A7r526 and rat aortic smooth muscle cells.27 Although the properties of Ca2+ channels may be different in cultured cells, our measurements of Ca2+ entry in aortic smooth muscle are consistent with these reports.

In the present study, aortic strips of SHR showed greater vascular reactivity and Ca2+ entry than those of WKY in all groups of rats. These results are consistent with other studies that have shown increased vascular tone in various blood vessels of SHR.13 14 15 16 The greater reduction in vascular reactivity and Ca2+ entry in intact female SHR and OVX female SHR with estrogen implants or in response to exogenous application of estrogen on isolated vascular strips of OVX female SHR compared with those in WKY could be due to differences in the number of estrogen receptors or in the number or permeability of the Ca2+ channels. This is supported by reports that the activity of the L-type Ca2+ channels is enhanced in vascular smooth muscle cells of SHR.28 29

The present study showed gender differences in the vascular reactivity and 45Ca2+ influx to maximal concentrations of phenylephrine and KCl. However, on the basis of these results, we do not wish to draw a general conclusion that similar gender differences also occur at all concentrations of phenylephrine and KCl. Comparison of the whole concentration-response curves to phenylephrine or KCl in rats of different gender should, therefore, represent an interesting area for future experiments. It is also important to note that exogenous estrogen caused vascular relaxation at concentrations severalfold higher than those observed in the plasma of intact females. Although both exogenous application of estrogen and the endogenous presence of estrogen were associated with reduction in vascular reactivity and Ca2+ entry, we do not wish to make a definite conclusion that the cellular mechanisms of estrogen-induced relaxation in vascular strips and the possible vasorelaxant effects of estrogen in vivo are identical. The effects of estrogen on target tissues have been classically thought of as arising from genomic actions mediated through interaction with cytoplasmic receptors and translocation of the hormone-receptor complex to the nucleus. Although a genomic action of estrogen on the expression of the Ca2+ channels might underlie the decreased responsiveness of aortic strips of intact females, it is less likely to account for the acute vasorelaxant effects of exogenous 17ß-estradiol. The acute nature of the vasorelaxant effects of exogenous estrogen may represent additional nongenomic effects of estrogen on the mechanisms of Ca2+ entry into vascular smooth muscle.

Finally, since the present study was performed on strips of thoracic aorta, we cannot make a definite conclusion on whether the observed gender differences in the Ca2+ entry mechanisms of arterial vasoconstriction also occur in resistance vessels, which should represent an important area for future investigation.

Thus, the vascular reactivity due to Ca2+ entry into vascular smooth muscle, but not Ca2+ release from intracellular stores, is reduced in the presence and enhanced in the absence of female gonads. The gender-specific changes in vascular reactivity and Ca2+ entry are possibly related to endogenous estrogen. The gender-specific changes in vascular reactivity and Ca2+ entry are enhanced in hypertension.


*    Acknowledgments
 
This work was supported by grants from the American Heart Association (Grant-in-Aid, Mississippi Affiliate) and the National Institutes of Health (HL-52696, HL-51971).


*    Footnotes
 
Reprint requests to Raouf A. Khalil, MD, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216.

Received May 8, 1999; first decision July 1, 1999; accepted July 14, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med.. 1976;85:447–452.

2. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10:615–624.[Abstract]

3. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation.. 1995;92:5–8.[Free Full Text]

4. Stampfer MJ, Colditz GA, Willett WC, Mason JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year followup from the Nurses's Health Study. N Engl J Med. 1991;325:756–762.[Abstract]

5. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 1988;244:19–22.[Abstract/Free Full Text]

6. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 1994;73:951–952.[Medline] [Order article via Infotrieve]

7. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17ß-estradiol in vitro. Br J Pharmacol. 1991;104:1033–1037.[Medline] [Order article via Infotrieve]

8. Harder DR, Coulson PB. Estrogen receptors and effects on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 1979;100:375–382.[Medline] [Order article via Infotrieve]

9. Khalil RA, van Breemen C. Mechanisms of calcium mobilization and homeostasis in vascular smooth muscle and their relevance to hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1995:523–540.

10. Crews JK, Khalil RA. Antagonistic effects of 17ß-estradiol, progesterone and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol. 1999;19:1034–1040.[Abstract/Free Full Text]

11. Landers JP, Spelsberg TC. New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr. 1992;2:19–63.[Medline] [Order article via Infotrieve]

12. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med. 1983;74:863–869.[Medline] [Order article via Infotrieve]

13. Mulvany MJ, Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71:585–596.[Medline] [Order article via Infotrieve]

14. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res. 1989;65:1475–1484.[Abstract/Free Full Text]

15. Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced vascular tone in the renal vasculature of spontaneously hypertensive rats. Hypertension. 1990;16:648–654.[Abstract/Free Full Text]

16. Falcone JC, Granger HJ, Meininger GA. Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol. 1993;265:H1847–H1855.[Abstract/Free Full Text]

17. Khalil RA, Van Breemen C. Sustained contraction of vascular smooth muscle: calcium influx or C-kinase activation? J Pharmacol Exp Ther. 1988;244:537–542.[Abstract/Free Full Text]

18. Leijeten PA, van Breemen C. The effects of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J Physiol. 1984;357:327–339.[Abstract/Free Full Text]

19. Stallone JN, Crofton JT, Share L. Sexual dimorphism in vasopressin-induced contraction of rat aorta. Am J Physiol. 1991;260:H453–H458.[Abstract/Free Full Text]

20. Tamaya T, Wada K, Nakagawa M, Misao R, Itoh T, Imai A, Mori H. Sexual dimorphism of binding sites of testosterone and dihydrotestosterone in rabbit model. Comp Biochem Physiol. 1993;105A:745–749.

21. Nakao J, Chang W, Murota S, Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Arteriosclerosis. 1981;38:75–80.

22. Lin AL, Shain SA. Estrogen mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis. 1985;5:668–677.[Abstract/Free Full Text]

23. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye J. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 1995;136:1523–1529.[Abstract]

24. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. 17ß-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995;92:24–30.[Abstract/Free Full Text]

25. Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall WA, Rubanyi GM. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol. 1997;110:135–140.[Abstract/Free Full Text]

26. Zhang F, Ram JL, Standley PR, Sowers JR. 17ß-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol. 1994;266:C975–C980.[Abstract/Free Full Text]

27. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata, Kurachi Y. 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle. Eur J Pharmacol. 1995;294:625–635.[Medline] [Order article via Infotrieve]

28. Kubo T, Taguchi K, Ueda M. L-type calcium channels in vascular smooth muscle cells from spontaneously hypertensive rats: effects of calcium agonist and antagonist. Hypertens Res. 1998;21:33–37.[Medline] [Order article via Infotrieve]

29. Martens JR, Gelband CH. Ion channels in vascular smooth muscle: alterations in essential hypertension. Proc Soc Exp Biol Med. 1998;218:192–203.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Xia and R. A. Khalil
Sex-related decrease in [Ca2+]i signaling and Ca2+-dependent contraction in inferior vena cava of female rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2010; 298(1): R15 - R24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. K. Stennett, X. Qiao, A. E. Falone, V. V. Koledova, and R. A. Khalil
Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H745 - H755.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. P. Kunert, M. R. Dwinell, I. Drenjancevic Peric, and J. H. Lombard
Sex-specific differences in chromosome-dependent regulation of vascular reactivity in female consomic rat strains from a SS x BN cross
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R516 - R527.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Bowles, K. K. Maddali, V. K. Ganjam, L. J. Rubin, D. L. Tharp, J. R. Turk, and C. L. Heaps
Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2091 - H2098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. A. Kanashiro and R. A. Khalil
Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle
Am J Physiol Cell Physiol, January 1, 2001; 280(1): C34 - C45.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crews, J. K.
Right arrow Articles by Khalil, R. A.